Nanjing Well Pharmaceutical Group Co. Ltd. Class ASSE: 603351

Report for Q3 2024

Oct 24, 2024 · Issued by Nanjing Well Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment